These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22929856)

  • 1. Imaging biomarker dynamics in an intracranial murine glioma study of radiation and antiangiogenic therapy.
    Chung C; Jalali S; Foltz W; Burrell K; Wildgoose P; Lindsay P; Graves C; Camphausen K; Milosevic M; Jaffray D; Zadeh G; Ménard C
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):805-12. PubMed ID: 22929856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy.
    Jalali S; Chung C; Foltz W; Burrell K; Singh S; Hill R; Zadeh G
    Neuro Oncol; 2014 Jun; 16(6):868-79. PubMed ID: 24759636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.
    Kong Z; Yan C; Zhu R; Wang J; Wang Y; Wang Y; Wang R; Feng F; Ma W
    Neuroimage Clin; 2018; 20():51-60. PubMed ID: 30069427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is apparent diffusion coefficient reliable and accurate for monitoring effects of antiangiogenic treatment in a longitudinal study?
    Suh JY; Cho G; Song Y; Lee CK; Kang JS; Kang MR; Park SB; Kim YR; Kim JK
    J Magn Reson Imaging; 2012 Jun; 35(6):1430-6. PubMed ID: 22314928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring the Vascular Response and Resistance to Sunitinib in Renal Cell Carcinoma
    Robinson SP; Boult JKR; Vasudev NS; Reynolds AR
    Cancer Res; 2017 Aug; 77(15):4127-4134. PubMed ID: 28566330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcoma.
    Yoon SS; Stangenberg L; Lee YJ; Rothrock C; Dreyfuss JM; Baek KH; Waterman PR; Nielsen GP; Weissleder R; Mahmood U; Park PJ; Jacks T; Dodd RD; Fisher CJ; Ryeom S; Kirsch DG
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1207-16. PubMed ID: 19545786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic Effect of Anti-Angiogenic and Radiation Therapy: Quantitative Evaluation with Dynamic Contrast Enhanced MR Imaging.
    Koo HJ; Lee M; Kim J; Woo CW; Jeong SY; Choi EK; Kim N; Lee JS
    PLoS One; 2016; 11(2):e0148784. PubMed ID: 26862906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy.
    Sahani DV; Jiang T; Hayano K; Duda DG; Catalano OA; Ancukiewicz M; Jain RK; Zhu AX
    J Hematol Oncol; 2013 Jul; 6():51. PubMed ID: 23842041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies.
    Wuthrick EJ; Kamrava M; Curran WJ; Werner-Wasik M; Camphausen KA; Hyslop T; Axelrod R; Andrews DW; Glass J; Machtay M; Dicker AP
    Cancer; 2011 Dec; 117(24):5548-59. PubMed ID: 21647871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma model.
    Hoff BA; Bhojani MS; Rudge J; Chenevert TL; Meyer CR; Galbán S; Johnson TD; Leopold JS; Rehemtulla A; Ross BD; Galbán CJ
    NMR Biomed; 2012 Jul; 25(7):935-42. PubMed ID: 22190279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-radiotherapy apparent diffusion coefficient (ADC) in children and young adults with high-grade gliomas and diffuse intrinsic pontine gliomas.
    Carceller F; Jerome NP; Fowkes LA; Khabra K; Mackinnon A; Bautista F; Marshall LV; Vaidya S; Mandeville H; Morgan V; Leach MO; Koh DM
    Pediatr Hematol Oncol; 2019 Mar; 36(2):103-112. PubMed ID: 30978130
    [No Abstract]   [Full Text] [Related]  

  • 12. Dynamic contrast-enhanced MRI for monitoring antiangiogenic treatment: determination of accurate and reliable perfusion parameters in a longitudinal study of a mouse xenograft model.
    Song Y; Cho G; Suh JY; Lee CK; Kim YR; Kim YJ; Kim JK
    Korean J Radiol; 2013; 14(4):589-96. PubMed ID: 23901316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic therapy inhibits the recruitment of vascular accessory cells to the perivascular niche in glioma angiogenesis.
    Parmaksız G; Czabanka M; Vinci M; Vajkoczy P
    J Vasc Res; 2014; 51(2):102-9. PubMed ID: 24556643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined temozolomide and sunitinib treatment leads to better tumour control but increased vascular resistance in O6-methylguanine methyltransferase-methylated gliomas.
    Czabanka M; Bruenner J; Parmaksiz G; Broggini T; Topalovic M; Bayerl SH; Auf G; Kremenetskaia I; Nieminen M; Jabouille A; Mueller S; Harms U; Harms C; Koch A; Heppner FL; Vajkoczy P
    Eur J Cancer; 2013 Jun; 49(9):2243-52. PubMed ID: 23499430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADC texture--an imaging biomarker for high-grade glioma?
    Brynolfsson P; Nilsson D; Henriksson R; Hauksson J; Karlsson M; Garpebring A; Birgander R; Trygg J; Nyholm T; Asklund T
    Med Phys; 2014 Oct; 41(10):101903. PubMed ID: 25281955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.
    Broggini T; Wüstner M; Harms C; Stange L; Blaes J; Thomé C; Harms U; Mueller S; Weiler M; Wick W; Vajkoczy P; Czabanka M
    Cancer Lett; 2016 Oct; 380(2):568-576. PubMed ID: 26297987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model.
    Valable S; Petit E; Roussel S; Marteau L; Toutain J; Divoux D; Sobrio F; Delamare J; Barré L; Bernaudin M
    Nucl Med Biol; 2011 Aug; 38(6):781-93. PubMed ID: 21843775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced magnetic resonance imaging for monitoring the anti-angiogenesis efficacy in a C6 glioma rat model.
    Hou W; Li X; Pan H; Xu M; Bi S; Shen Y; Yu Y
    Acta Radiol; 2020 Jul; 61(7):973-982. PubMed ID: 31739674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monochromatic minibeams radiotherapy: from healthy tissue-sparing effect studies toward first experimental glioma bearing rats therapy.
    Deman P; Vautrin M; Edouard M; Stupar V; Bobyk L; Farion R; Elleaume H; Rémy C; Barbier EL; Estève F; Adam JF
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e693-700. PubMed ID: 22270173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy.
    Cao Y; Tsien CI; Shen Z; Tatro DS; Ten Haken R; Kessler ML; Chenevert TL; Lawrence TS
    J Clin Oncol; 2005 Jun; 23(18):4127-36. PubMed ID: 15961760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.